Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghiorzo

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
Cancer Metastasis Reviews|March 12, 2017
Identification, genetic testing, and management of hereditary melanomaSancy A Leachman, Olivia M Lucero, Jone E Sampson, et al.
Biochemical and Biophysical Research Communications|June 5, 1996
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kappa B/Rel family membersM Musso, P Ghiorzo, P Fiorentini, et al.
Melanoma Research|June 1, 1996
MEL-P, a GM-CSF-producing human melanoma cell lineP Ciotti, A Imro, M Scudeletti, et al.
Plos One|December 8, 2017
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer developmentWilliam Bruno, Virginia Andreotti, Alessandra Bisio, et al.
The Journal of Investigative Dermatology|September 18, 2009
Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterationsBraslav Jovanovic, Suzanne Egyhazi, Malihe Eskandarpour, et al.
Frontiers in Molecular Biosciences|August 28, 2020
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical ImplicationsIrene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, et al.
American Journal of Medical Genetics. Part A|June 18, 2009
Identification of a SUFU germline mutation in a family with Gorlin syndromeL Pastorino, P Ghiorzo, S Nasti, et al.
Dermatology Reports|September 4, 2025
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomesAndrea Carugno, Emanuela Passoni, Giovanna Pogliaghi, et al.
International Journal of Cancer|July 18, 2000
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activityM Morini, M Mottolese, N Ferrari, et al.
Endocrine|August 23, 2015
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancerClaudia Martinuzzi, Lorenza Pastorino, Virginia Andreotti, et al.
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
Cancer Metastasis Reviews|March 12, 2017
Identification, genetic testing, and management of hereditary melanomaSancy A Leachman, Olivia M Lucero, Jone E Sampson, et al.
Biochemical and Biophysical Research Communications|June 5, 1996
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kappa B/Rel family membersM Musso, P Ghiorzo, P Fiorentini, et al.
Melanoma Research|June 1, 1996
MEL-P, a GM-CSF-producing human melanoma cell lineP Ciotti, A Imro, M Scudeletti, et al.
Plos One|December 8, 2017
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer developmentWilliam Bruno, Virginia Andreotti, Alessandra Bisio, et al.
The Journal of Investigative Dermatology|September 18, 2009
Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterationsBraslav Jovanovic, Suzanne Egyhazi, Malihe Eskandarpour, et al.
Frontiers in Molecular Biosciences|August 28, 2020
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical ImplicationsIrene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, et al.
American Journal of Medical Genetics. Part A|June 18, 2009
Identification of a SUFU germline mutation in a family with Gorlin syndromeL Pastorino, P Ghiorzo, S Nasti, et al.
Dermatology Reports|September 4, 2025
Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomesAndrea Carugno, Emanuela Passoni, Giovanna Pogliaghi, et al.
International Journal of Cancer|July 18, 2000
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activityM Morini, M Mottolese, N Ferrari, et al.
Endocrine|August 23, 2015
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancerClaudia Martinuzzi, Lorenza Pastorino, Virginia Andreotti, et al.
Pageof 15